UA101065C2 - Местный препарат 3-(2,2,2-триметилгидразиний)пропионата дигидрата - Google Patents

Местный препарат 3-(2,2,2-триметилгидразиний)пропионата дигидрата

Info

Publication number
UA101065C2
UA101065C2 UAA201105447A UAA201105447A UA101065C2 UA 101065 C2 UA101065 C2 UA 101065C2 UA A201105447 A UAA201105447 A UA A201105447A UA A201105447 A UAA201105447 A UA A201105447A UA 101065 C2 UA101065 C2 UA 101065C2
Authority
UA
Ukraine
Prior art keywords
trimethylhydrazinium
propionate dihydrate
topical formulation
dihydrate
propionate
Prior art date
Application number
UAA201105447A
Other languages
English (en)
Ukrainian (uk)
Inventor
Малімон Георгі
Original Assignee
Гріндекс, Е Джоінт Сток Компані
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гріндекс, Е Джоінт Сток Компані filed Critical Гріндекс, Е Джоінт Сток Компані
Publication of UA101065C2 publication Critical patent/UA101065C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Изобретение относится к медицине и касается гелевой композиции 3-(2,2,2-триметилгидразиний)пропионата дигидрата для местного введения через кожу. Композиция по изобретению содержит мелдония дигидрат и карбомер Карбопол 980 в качестве сгустителя.
UAA201105447A 2008-10-29 2009-10-29 Местный препарат 3-(2,2,2-триметилгидразиний)пропионата дигидрата UA101065C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08167825 2008-10-29
PCT/EP2009/064285 WO2010049485A2 (en) 2008-10-29 2009-10-29 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate

Publications (1)

Publication Number Publication Date
UA101065C2 true UA101065C2 (ru) 2013-02-25

Family

ID=40379697

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201105447A UA101065C2 (ru) 2008-10-29 2009-10-29 Местный препарат 3-(2,2,2-триметилгидразиний)пропионата дигидрата

Country Status (6)

Country Link
EP (1) EP2340016B1 (ru)
CN (1) CN102202651A (ru)
EA (1) EA018384B1 (ru)
GE (1) GEP20135819B (ru)
UA (1) UA101065C2 (ru)
WO (1) WO2010049485A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106008257A (zh) * 2016-03-16 2016-10-12 江苏悦兴药业有限公司 米屈肼的制备方法及其关键中间体
CN105853349A (zh) * 2016-04-29 2016-08-17 济南康和医药科技有限公司 一种米屈肼注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386014T1 (de) * 2003-08-04 2008-03-15 Grindeks Jsc Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EA201100575A1 (ru) 2011-12-30
WO2010049485A2 (en) 2010-05-06
EP2340016B1 (en) 2013-01-23
EA018384B1 (ru) 2013-07-30
GEP20135819B (en) 2013-05-10
WO2010049485A3 (en) 2010-07-08
CN102202651A (zh) 2011-09-28
EP2340016A2 (en) 2011-07-06

Similar Documents

Publication Publication Date Title
EA201170527A1 (ru) Фармацевтические композиции, включающие соединения бороновой кислоты
MX2011011514A (es) Formulaciones de canabidiol y metodos para utilizarlas.
TW200603787A (en) Topical preparations containing ambroxol
MX2009000507A (es) Espuma farmaceutica de acidos grasos.
MX2010008802A (es) Formulacion liquida de la fsh.
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
MX2010009623A (es) Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
WO2008094910A3 (en) Hyaluronate compositions
WO2010070675A3 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
BR112012003283A2 (pt) sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, composição farmacêutica, produto, kit, uso de um sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, e, método de introdução de uma molécula de medicamento no citosol de uma célula em um paciente.
MX344476B (es) Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal.
MX347927B (es) Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb.
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
EP1778209B8 (en) Methods and compositions for oral delivery of fts
MX2012007225A (es) Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
WO2012099899A3 (en) Topical dermatological compositions for the treatment of acne
WO2008051527A3 (en) Sustained release of agents for localized pain management
BR112013006651A2 (pt) composição e cocristal de aprepitante l-prolina
UA101065C2 (ru) Местный препарат 3-(2,2,2-триметилгидразиний)пропионата дигидрата
IN2014DN10134A (ru)
MD2516C2 (ru) Противовоспалительное, антисептическое и противогрибковое лекарственное средство в форме геля
IN2013MU03390A (ru)